Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis

Author(s):
Fontein, D.B.Y.; Seynaeve, C.; Hadji, P.; Hille, E.T.M.; Water, W.V. de; Putter, H.; Kranenbarg, E.M.K.; Hasenburg, A.; Paridaens, R.J.; Vannetzel, J.M.; Markopoulos, C.; Hozumi, Y.; Bartlett, J.M.S.; Jones, S.E.; Rea, D.W.; Nortier, J.W.R.; Velde, C.J.H. van de (0000-0003-0104-1800)
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-06-20
Language
English
Is part of
Journal of Clinical Oncology (2013), Vol. 31, no. 18, p. 2257-U59
hdl
1887/102052
doi
10.1200/JCO.2012.45.3068